IL6 and obesity due to melanocortin 4 receptor deficiency: Higher circulating concentrations of IL-6 have also been associated with obesity and visceral adipose tissue (VAT) deposition [2,3,4], lipid metabolism [1] and increased risk for cardiovascular disease (CVD) [5].